Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 9
July 2020
Volume 61, Issue 9
Free
ARVO Imaging in the Eye Conference Abstract  |   July 2020
Transient change of large vessels in diabetics after anti-VEGF injection
Author Affiliations & Notes
  • Katherine Makedonsky
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Ali Fard
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Mary Durbin
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Subhransu Ray
    Bay Area Retina Associates, Walnut Creek, California, United States
  • Footnotes
    Commercial Relationships   Katherine Makedonsky, Carl Zeiss Meditec, Inc (E); Ali Fard, Carl Zeiss Meditec, Inc (E); Mary Durbin, Carl Zeiss Meditec, Inc (E); Subhransu Ray, Carl Zeiss Meditec, Inc (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2020, Vol.61, PB0030. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katherine Makedonsky, Ali Fard, Mary Durbin, Subhransu Ray; Transient change of large vessels in diabetics after anti-VEGF injection. Invest. Ophthalmol. Vis. Sci. 2020;61(9):PB0030.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Vascular Endothelial Growth Factor (VEGF) production is trigged in response to ischemia or hypoxia in the retina, common in patients with diabetic retinopathy. Anti-VEGF injection has been shown to cause a transient decrease in perfusion in the optic nerve peripapillary region [Wen et al., J Glaucoma 2019; 28 (3)]. The purpose of this study was to evaluate the acute effect of anti-VEGF on the large blood vessels alone.

Methods : Optic Nerve Head (ONH) Angio 4.5x4.5 mm scans were obtained with using CIRRUS™ HD-OCT 5000 with AngioPlex® OCT Angiography (ZEISS, Dublin, CA) on diabetics receiving anti-VEGF as part of clinical care. Scans were taken prior to injection, and post-injection at 1, 10 and 20 minutes. ONH perfusion and flux were calculated based on the vasculature network between internal limiting membrane and retinal nerve fiber layer. The algorithm used in the instrument automatically excludes large vessels. Vessels that created a shadow in the structural en face around the RPE layer are deemed large. Perfusion is the total area of perfused vasculature/unit area in region of interest (ROI). Flux is the total area of perfused vasculature/unit area in ROI, weighted by the flow signal intensity. Perfusion and flux were calculated at each time point including only large vessels. Percent change was calculated relative to baseline at each time interval.

Results : Peripapillary large blood vessels in 15 eyes of 12 patients (age: 58 +/-13 years) were evaluated. 5 of 15 eyes had neovascularization of the disc (NVD). Figure 1 shows an example of the large vessels included. The mean percent change for perfusion at 1, 10, 20 minutes was 1 ± 7%, 3 ± 9%, 1± 8%, and the mean percent change for flux at 1, 10, 20 minutes was 0± 6%, -2± 8%, -2± 5% (see Figure 2 A&B).

Conclusions : Transient change in perfusion was previously demonstrated in the small capillary network following Anti-VEGF injection; however, the observed changes were not significant in the large blood vessels in this study. The fluctuations in flux and perfusion were variable, not correlating with the presence of NVD. This study suggests that transient changes in the small capillary network may be more sensitive than changes in large vessels following anti-VEGF injection.

This is a 2020 Imaging in the Eye Conference abstract.

 

Figure 1. ONH OCTA with highlight of only large vessels

Figure 1. ONH OCTA with highlight of only large vessels

 

Figure 2. Percentage difference in perfusion and flux with time

Figure 2. Percentage difference in perfusion and flux with time

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×